tiprankstipranks
Company Announcements

HEALWELL’s Pentavere Validates DARWEN™ AI in Lung Cancer Treatment Study

Story Highlights
HEALWELL’s Pentavere Validates DARWEN™ AI in Lung Cancer Treatment Study

Discover the Best Stocks and Maximize Your Portfolio:

MCI Onehealth Technologies, Inc. Class A ( (TSE:AIDX) ) has provided an update.

HEALWELL AI Inc.’s subsidiary, Pentavere, has published a study in the ‘Journal of Liquid Biopsy’ validating its DARWEN™ AI platform as a leading clinical decision support tool in oncology. The study, conducted in collaboration with Princess Margaret Cancer Centre, highlights the platform’s ability to save time and improve lung cancer treatment through the use of liquid biopsies, which offer a less invasive alternative to traditional methods. By enabling fast and accurate data extraction, DARWEN™ AI is advancing personalized cancer care and precision medicine.

More about MCI Onehealth Technologies, Inc. Class A

HEALWELL AI Inc. is a healthcare artificial intelligence company focused on preventative care. Its subsidiary, Pentavere Research Group, is a globally recognized AI digital health company specializing in clinical decision support tools in oncology.

YTD Price Performance: -15.94%

Average Trading Volume: 599,674

Technical Sentiment Consensus Rating: Sell

Current Market Cap: C$347.4M

Find detailed analytics on AIDX stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1